tiprankstipranks
Trending News
More News >
SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market
Advertisement

SynAct Pharma AB (8F8) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
SynAct Pharma AB’s (8F8) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting SynAct Pharma AB is a Buy.
SynAct Pharma AB’s (8F8) 20-Day exponential moving average is 1.73, while SynAct Pharma AB’s (8F8) share price is €1.62, making it a Sell.
SynAct Pharma AB’s (8F8) 50-Day exponential moving average is 1.71, while SynAct Pharma AB’s (8F8) share price is €1.62, making it a Sell.

SynAct Pharma AB (8F8) Pivot Points

Aug 19, 2025, 04:45 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.60
1.61
1.63
1.64
1.66
1.67
1.69
Fibonacci
1.61
1.62
1.63
1.64
1.65
1.66
1.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SynAct Pharma AB (8F8) Moving Averages

Aug 19, 2025, 04:45 PM
Period
Simple
Exponential
MA5
1.67Sell
1.67Sell
MA10
1.70Sell
1.71Sell
MA20
1.77Sell
1.73Sell
MA50
1.69Sell
1.71Sell
MA100
1.65Buy
1.61Buy
MA200
1.36Buy
1.35Buy
SynAct Pharma AB’s (8F8) 10-Day exponential moving average is 1.71, while SynAct Pharma AB’s (8F8) share price is €1.62, making it a Sell.
SynAct Pharma AB’s (8F8) 100-Day exponential moving average is 1.61, while SynAct Pharma AB’s (8F8) share price is €1.62, making it a Buy.
SynAct Pharma AB’s (8F8) stock price is €1.62 and SynAct Pharma AB’s (8F8) 50-day simple moving average is 1.69, creating a Sell signal.
SynAct Pharma AB’s (8F8) stock price is €1.62 and SynAct Pharma AB’s (8F8) 100-day simple moving average is 1.65, creating a Buy signal.
SynAct Pharma AB’s (8F8) stock price is €1.62 and SynAct Pharma AB’s (8F8) 200-day simple moving average is 1.36, creating a Buy signal.

SynAct Pharma AB (8F8) Technical Indicators

Aug 19, 2025, 04:45 PM
Name
Value
Implied Action
RSI (14)
41.16
Neutral
STOCH (9,6)
15.93
Buy
STOCHRSI (14)
10.97
Buy
MACD (12,26)
-0.02
Buy
ADX (14)
16.81
Buy
Williams %R
-91.14
Buy
CCI (14)
-67.01
Neutral
ATR (14)
0.08
-
Ultimate Oscillator
45.93
Neutral
ROC
-13.16
Sell
SynAct Pharma AB’s (8F8) Relative Strength Index (RSI) is 41.16, creating a Neutral signal.
SynAct Pharma AB’s (8F8) Trend Strength Indicator (ADX) is 16.81, creating a Buy signal.
SynAct Pharma AB’s (8F8) Commodity Channel Index (CCI) is -67.01, creating a Neutral signal.
SynAct Pharma AB’s (8F8) Price Rate of Change (ROC) is -13.16, creating a Sell signal.

FAQ

Is 8F8 a Buy, Hold, or Sell?
Based on 8F8’s technical indicators, 8F8 is a Hold.
    What is 8F8’s RSI (14)?
    8F8’s RSI (14) is 41.16, which suggests 8F8 is a Neutral.
      What is 8F8’s MACD?
      8F8’s MACD is -0.02, which suggests 8F8 is a Buy.
        What is 8F8’s 5-day moving average?
        8F8’s 5-day moving average is 1.67, which suggests 8F8 is a Sell.
          What is 8F8’s 20-day moving average?
          8F8 20-day moving average is 1.77, which suggests 8F8 is a Sell.
            What is 8F8’s 50-day moving average?
            8F8’s 50-day moving average is 1.69, which suggests 8F8 is a Sell.
              What is 8F8’s 200-day moving average?
              8F8’s 200-day moving average is 1.36, which suggests 8F8 is a Buy.
                What is 8F8’s Williams % R (14)?
                8F8’s Williams % R (14) is -91.14, which suggests 8F8 is a Buy.
                  What is 8F8’s CCI (14)?
                  8F8’s CCI (14) is -67.01, which suggests 8F8 is a Neutral.
                    What is the share price of SynAct Pharma AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis